-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
Inhibikase Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2021 to Q3 2024.
- Inhibikase Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -202 %, a 146% decline year-over-year.
- Inhibikase Therapeutics, Inc. annual Return On Assets for 2023 was -91.8 %, a 60.1% decline from 2022.
- Inhibikase Therapeutics, Inc. annual Return On Assets for 2022 was -57.4 %, a 44.9% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)